Preferential Deamination of Dopamine by an A Type Monoamine Oxidase in Rat Brain

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1976 Jan 14

PMID 934359

Citations 29

Authors

P C Waldmeier

A Delini-Stula

L Maitre

Affiliations

Soon will be listed here.

Abstract

The effect of graded doses of clorgyline, a preferential inhibitor of MAO A, and of deprenil, a preferential inhibitor of MAO B, on the activities of serotonin-deaminating MAO (MAO A) of dopamine-deaminating MAO, and of phenethylamine-deaminating MAO, (MAO B), in rat corpus striatum were compared with the effects of the drugs on striatal levels of homovanillic acid(HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC). The dose-response curves for the two last-mentioned dopamine metabolites closely follow those for MAO A and dopamine-deaminating activity, whether clorgyline or deprenil was used as MAO inhibitor. In addition, the effect of these drugs on dopamine levels and on the accumulation of 3H-dopamine + 3H-methoxytyramine formed from 3H-DOPA in rat whole brain was analysed. In contrast to the marked increases caused by clorgyline, the effects of deprenil were negligible. In reserpinized rats, clorgyline potentiated the effect of L-DOPA on motor activity; deprenil did not. These results suggest that the deamination of dopamine in vivo is almost entirely effected by MAO A.

Citing Articles

Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline.

Harsing Jr L, Timar J, Miklya I Int J Mol Sci. 2023; 24(17).

PMID: 37686140 PMC: 10487936. DOI: 10.3390/ijms241713334.

Revisiting the Role of Astrocytic MAOB in Parkinson's Disease.

Nam M, Sa M, Ju Y, Park M, Lee C Int J Mol Sci. 2022; 23(8).

PMID: 35457272 PMC: 9028367. DOI: 10.3390/ijms23084453.

Neuropharmacology of N,N-dimethyltryptamine.

Carbonaro T, Gatch M Brain Res Bull. 2016; 126(Pt 1):74-88.

PMID: 27126737 PMC: 5048497. DOI: 10.1016/j.brainresbull.2016.04.016.

Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.

Kleinridders A, Cai W, Cappellucci L, Ghazarian A, Collins W, Vienberg S Proc Natl Acad Sci U S A. 2015; 112(11):3463-8.

PMID: 25733901 PMC: 4371978. DOI: 10.1073/pnas.1500877112.

Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.

Sader-Mazbar O, Loboda Y, Rabey M, Finberg J Br J Pharmacol. 2013; 170(5):999-1013.

PMID: 23992249 PMC: 3949649. DOI: 10.1111/bph.12349.

References

Neff N, Goridis C . Neuronal monoamine oxidase: specific enzyme types and their rates of formation. Adv Biochem Psychopharmacol. 1972; 5:307-23. View

Youdim M . Multiple forms of mitochondrial monoamine oxidase. Br Med Bull. 1973; 29(2):120-2. DOI: 10.1093/oxfordjournals.bmb.a070980. View

Youdim M . Multiple forms of monoamine oxidase and their properties. Adv Biochem Psychopharmacol. 1972; 5:67-77. View

Goridis C, Neff N . Evidence for a specific monoamine oxidase associated with sympathetic nerves. Neuropharmacology. 1971; 10(5):557-64. DOI: 10.1016/0028-3908(71)90021-9. View

Graeff F . The role of dopamine in motor excitation of mice induced by brain catecholamine releasers. J Pharm Pharmacol. 1966; 18(9):627-8. DOI: 10.1111/j.2042-7158.1966.tb07947.x. View

Wurtman R, Axelrod J . A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. Biochem Pharmacol. 1963; 12:1439-41. DOI: 10.1016/0006-2952(63)90215-6. View

Murphy G, Robinson D, SHARMAN D . The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse. Br J Pharmacol. 1969; 36(1):107-15. PMC: 1703540. DOI: 10.1111/j.1476-5381.1969.tb08308.x. View

Kroon M, VELDSTRA H . Multiple forms of rat brain mitochondrial monoamine oxidase. Subcellular localization. FEBS Lett. 1972; 24(2):173-176. DOI: 10.1016/0014-5793(72)80760-9. View

Johnston J . Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol. 1968; 17(7):1285-97. DOI: 10.1016/0006-2952(68)90066-x. View

10.

Grahame-Smith D, Green A . Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor. Br J Pharmacol. 1974; 50(3):442P-443P. PMC: 1776657. View

11.

Atack C, Magnusson T . Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J Pharm Pharmacol. 1970; 22(8):625-7. DOI: 10.1111/j.2042-7158.1970.tb10584.x. View

12.

Ahlenius S, Engel J . Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats. Naunyn Schmiedebergs Arch Pharmakol. 1971; 270(4):349-60. DOI: 10.1007/BF01002347. View

13.

Collins G, Sandler M, Williams E, Youdim M . Multiple forms of human brain mitochondrial monoamine oxidase. Nature. 1970; 225(5235):817-20. DOI: 10.1038/225817a0. View

14.

Waldmeier P, Maitre L . Proceedings: Lack of significance of MAO-B for in vivo deamination of dopamine. Naunyn Schmiedebergs Arch Pharmacol. 1975; 287 Suppl:R2. View

15.

Hall D, Logan B, Parsons G . Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species. Biochem Pharmacol. 1969; 18(6):1447-54. DOI: 10.1016/0006-2952(69)90258-5. View

16.

Yang H, Neff N . Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther. 1973; 187(2):365-71. View

17.

CORRODI H, Fuxe K . The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition. Life Sci. 1967; 6(13):1345-50. DOI: 10.1016/0024-3205(67)90179-8. View

18.

Waldmeier P, De Herdt P, Maitre L . Simultaneous automated estimation of noradrenaline and dopamine in brain tissue. Clin Chem. 1974; 20(1):81-3. View

19.

Kim H, Diorio A . Possible isoenzymes of monoamine oxidase in rat tissues. Can J Biochem. 1968; 46(4):295-7. DOI: 10.1139/o68-044. View

20.

Yang H, Neff N . The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J Pharmacol Exp Ther. 1974; 189(3):733-40. View